News
Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears ...
EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court ...
Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola ...
US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.
As the US legal sector comes under political pressure for its inclusion efforts, LSIPR's sister magazine reveals its Top 100 ...
Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret ...
14 April 2025 Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device ...
Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
The firm hired Brent Babcock as a partner in New York, bringing experience in cases involving biotechnology and medical ...
Following the Unified Patent Court’s recent Meril v Edwards decision, Agathe Michel-de Cazotte & Ben Chapman of Carpmaels & Ransford examine the court’s treatment of obviousness to date.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results